...
首页> 外文期刊>International Journal of Cardiology >High prevalence of male hypogonadism and sexual dysfunction in long-term clinically stable heart transplantation recipients
【24h】

High prevalence of male hypogonadism and sexual dysfunction in long-term clinically stable heart transplantation recipients

机译:长期临床稳定的心脏移植患者中男性性腺功能低下和性功能障碍的患病率较高

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The impact of gonadic and sexual function on male heart transplantation (HTX) recipients has been scarcely investigated so far. The aim of this observational study was a long-term evaluation of the gonadic and sexual function in male HTX recipients. A total of 52 patients, aged 20-78 years (mean +- SD: 54.2 +- 15.2) were included. The time interval elapsed since HTX was 88 +- 65.3 months (range 4-220). All recipients were clinically stable, with a mean left ventricle ejection fraction (LVEF) 57.9 +-5.8% (range 40-65) and NYHA class I (86.5%) or II (13.5%). Most (88.5%) were on anti-hypertensive drugs and all were treated with immunosuppres-sive therapy including calcineurin inhibitors (cyclosporine, everolimus), azathioprine or mycophenolate-mofetil. Thirty-four patients were also on low-dose prednisone. Cardiac allograft vasculopathy (CAV)>grade 1 was detected at coronary artery angiography in 11 patients (21.2%) [1].
机译:到目前为止,几乎没有研究过性功能对男性心脏移植(HTX)受者的影响。这项观察性研究的目的是对男性HTX接受者的性腺和性功能进行长期评估。包括52名年龄在20-78岁的患者(平均±标准差:54.2±15.2)。自HTX以来经过的时间间隔为88±65.3个月(范围4-220)。所有接受者均临床稳定,平均左心室射血分数(LVEF)为57.9±-5.8%(范围40-65)和NYHA I级(86.5%)或II级(13.5%)。大多数(88.5%)服用抗高血压药,并且全部接受了免疫抑制疗法的治疗,包括钙调神经磷酸酶抑制剂(环孢霉素,依维莫司),硫唑嘌呤或霉酚酸酯。 34例患者也接受小剂量泼尼松治疗。 11例患者(21.2%)在冠状动脉造影中发现心脏同种异体血管病变(CAV)> 1级。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号